About Aaron Missere

Aaron Missere is the CEO and founder of financial media company Departures Capital Inc. He is an avid and experienced investor, with a primary focus on the cannabis industry. In addition to being a featured contributor to StockNews.com and ETFDailyNews.com, he is an author for SmarterAnalyst.com. Aaron also currently hosts a weekly show on YouTube that recaps and explains the movement in the stock market, with a heavy emphasis on marijuana stocks.

Recent Articles By Aaron Missere

: HEXO |  News, Ratings, and Charts

Has Marijuana Stock HEXO Corp. (HEXO) Found a Bottom?

This past month HEXO has shown stability, holding onto $2 per share, and many investors are speculating that this could be the bottom.
: TLRY |  News, Ratings, and Charts

Are Shares of Tilray (TLRY) a Buy?

This week Tilray announced that former Mattel and General Mills executive Katy Dickson has joined the companies leadership team.
: CGC |  News, Ratings, and Charts

What Can We Expect to Learn from Canopy Growth's (CGC) Investor Meeting?

Canopy Growth Corp., the largest cannabis company in the world by market cap, has had a few disappointing quarters recently.
: ACB |  News, Ratings, and Charts

2 Pieces of Good News for Aurora Cannabis (ACB)

Recently, shares of Aurora Cannabis (ACB) have had a bumpy ride but this week we saw some good news released for the company.
: OGI |  News, Ratings, and Charts

Are Shares of Organigram (OGI) a Buy, After Their Weak Fourth Quarter?

The recent round of earnings for the vast majority of large-cap cannabis companies in Canada has been weak. 
: ACB |  News, Ratings, and Charts

Is the Worst Over for Shares of Aurora Cannabis (ACB)?

It's been a bumpy ride for Aurora Cannabis (ACB) shareholders over the past two weeks.
: IIPR |  News, Ratings, and Charts

Will the rally continue for Innovative Industrial Properties (IIPR)?

Despite the challenging environment in the cannabis sector at this time, Innovative Industrial Properties (IIPR) has been bucking the trend when it comes to stock performance. 
: ACB |  News, Ratings, and Charts

Is Cannabis Stock Aurora Cannabis (ACB) a Buy?

This week started off with the cannabis sector plunging into the red with double-digit losses for many large-cap stocks. Aurora Cannabis was among one of the biggest decliners in the market. 
: CGC |  News, Ratings, and Charts

Canopy Growth: Sell, Buy or Hold?

To simply put it, these numbers weren’t good, and as a result shares slid 15% the day of earnings to fresh 52-week lows. 
: ACB |  News, Ratings, and Charts

Is Now the Time to Buy Aurora Cannabis (ACB)?

Aurora Cannabis reported its Q1 2020 financial results after the market closed yesterday, Thursday, November 14th, 2019.
Page generated in 0.0051 seconds.